Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Table 7.B - Retatrutide Phase 2 Responder Rates (12 mg arm, 48 weeks) Source: Phase 2 obesity trial (NCT04881760), 12 mg arm
Tirzepatide: Which Medication is Best
Regular monitoring ensures your safety and helps maximize your results
Available forms Oral capsules or tablets the most common format for wellness protocols Topical cream or gel may offer transdermal delivery Powder form for compounding allows flexible dosing by qualified pharmacies Subcutaneous injection used in some clinical settings under physician supervision General dosage reference (investigational) Due to Dihexas extraordinary potency and the theoretical concern that excessive HGF/c-Met activation could promote unwanted cellular growth in susceptible individuals conservative dosing and careful medical supervision are strongly emphasized by experienced practitioners
Elevated IGF-1 levels raise concerns about potential proliferative effects on existing malignancies, making growth hormone therapy problematic for individuals with cancer history or elevated cancer risk
Gobburu JV, Agers H, Jusko WJ, Ynddal L Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers
US$ 27.89
US$ 23.73
US$ 29.18
US$ 24.20
US$ 20.61
US$ 23.21
US$ 27.18
US$ 25.28
